Optometry and Visual Sciences, School of Health Sciences, City, University of London Northampton Square, London, EC1V 0HB, UK.
Moorfield's Eye Hospital NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Sci Rep. 2021 Apr 15;11(1):8323. doi: 10.1038/s41598-021-86193-3.
In age-related macular degeneration (AMD) research, dark adaptation has been found to be a promising functional measurement. In more severe cases of AMD, dark adaptation cannot always be recorded within a maximum allowed time for the test (~ 20-30 min). These data are recorded either as censored data-points (data capped at the maximum test time) or as an estimated recovery time based on the trend observed from the data recorded within the maximum recording time. Therefore, dark adaptation data can have unusual attributes that may not be handled by standard statistical techniques. Here we show time-to-event analysis is a more powerful method for analysis of rod-intercept time data in measuring dark adaptation. For example, at 80% power (at α = 0.05) sample sizes were estimated to be 20 and 61 with uncapped (uncensored) and capped (censored) data using a standard t-test; these values improved to 12 and 38 when using the proposed time-to-event analysis. Our method can accommodate both skewed data and censored data points and offers the advantage of significantly reducing sample sizes when planning studies where this functional test is an outcome measure. The latter is important because designing trials and studies more efficiently equates to newer treatments likely being examined more efficiently.
在年龄相关性黄斑变性(AMD)研究中,暗适应已被发现是一种很有前途的功能测量方法。在 AMD 更严重的情况下,暗适应测试不能总是在最大允许时间内完成(~20-30 分钟)。这些数据要么被记录为删失数据点(数据上限为最大测试时间),要么根据最大记录时间内记录的数据趋势进行估计恢复时间。因此,暗适应数据可能具有不寻常的属性,这些属性可能无法通过标准统计技术来处理。在这里,我们展示了事件时间分析是一种更强大的方法,可用于分析测量暗适应的杆截距时间数据。例如,在 80%的功效(α=0.05)下,使用标准 t 检验对无上限(无删失)和上限(删失)数据进行估计,样本量分别为 20 和 61;当使用建议的事件时间分析时,这些值分别提高到 12 和 38。我们的方法可以同时处理偏态数据和删失数据点,并在计划以该功能测试为结果测量的研究时具有显著减少样本量的优势。后者很重要,因为更有效地设计试验和研究相当于更有效地检查新的治疗方法。